Ruolo dell'Infliximab nella terapia della colite ulcerosa moderato-severa
Background: Almost 10-15% of patients with active Ulcerative Colitis are refractory to conventional therapy. Infliximab is a treatment of proven efficacy in this group of patients. Aims: To evaluate the role of Inliximab in inducing and maintaining remission in patients with chronically active mode...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Doctoral Thesis |
| Language: | it |
| Published: |
Alma Mater Studiorum - Università di Bologna
2009
|
| Subjects: | |
| Online Access: | http://amsdottorato.unibo.it/2241/ |